Brittany Meisenheimer

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

1h-index84citations7works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(4), Immune Cell Function and Interaction(3), Immune cells in cancer(2), CAR-T cell therapy research(2), Cancer Cells and Metastasis(1)

Publications7 total

Abstract 162: Individualizing treatment using patient derived organoids, BH3 profiling and microfluidics: A proof of concept in a patient with low-grade serous ovarian carcinoma
Cancer Research·2023· 1 cited
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023· 1 citedOpen Access
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
2023Open Access
Abstract 4168: Tumor cell stimulator of interferon genes (STING) activation primes NK cell therapy in mesothelioma
Cancer Research·2022
Activation of Tumor-Cell STING Primes NK-Cell Therapy
Cancer Immunology Research·2022· 82 citedOpen Access

Frequent Co-authors

Elena V. Ivanova(7), Ha Vo(7), Cloud P. Paweletz(7), Erik H. Knelson(6), Mubin Tarannum(6), Marco Campisi(6), Patrick H. Lizotte(6), Matthew A. Booker(6), Minyue Chen(6), Nathaniel Spicer(6), Bonje Obua(6), Thomas P. Albertson(6), Marina Vivero(6), Michael Tolstorukov(6), Rizwan Romee(6), Raphael Bueno(6), David A. Barbie(6), Ismail Ozgenc(5), Moataz Noureddine(5), Brandon Piel(5)